Posts tagged ‘Oncology’
February 23rd, 2011
One of the emerging companies whose new product development and marketing strategy we have been watching is AB Science. Sally Church on Pharma Strategy Blog has interviewed the CEO, Alain Moussy as part of her series on pharmaceutical, biotechnology industry leaders who are making a difference.
AB Science is a Paris based emerging pharmaceutical company. We think that they have some innovative approaches to new product development in oncology and inflammation.
Pieter Droppert on Biotech Strategy Blog has written the latest update in a series of posts about the company, their pipeline and clinical trials. AB Science is a company worth taking a look at.
February 15th, 2011
Sally Church on Pharma Strategy Blog analyzes a recent study published in Cancer, Epidemiology, Biomarkers and Prevention, that suggests there is a reduced risk of high grade glioma if you have allergies.
Why is this the case? Sally looks closely at whether this is a valid or spurious correlation.
February 9th, 2011
Sally Church on Pharma Strategy Blog discusses a recent paper from Science and Translational Medicine, in which new research shows that endothelial cells (fibroblasts, immune cells) actively participate in regulating the cancer tumor microenvironment.
Further insight on why stromal-cancer cross talk is becoming a hot-topic, can be found on Pharma Strategy Blog.
February 5th, 2011
The US Food & Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) approved 15 new molecular entities (NME) and 6 new biologics in 2010. The approval trend has been downward since 1996.
Sally Church on Pharma Strategy Blog provides insight on what we should expect in the future for oncology.
February 2nd, 2011
A recent paper in The Journal of Clinical Investigation by Lee et al, presents interesting results on the use of N-terminal truncated carboxypeptidase E splice isoform as a biomarker to predict cancer metastasis.
You can read Sally Church’s analysis about whether we can predict when cancer will spread on the Pharma Strategy Blog.
January 11th, 2011
Published by Sally Church on Pharma Strategy Blog
January 4th, 2011
Sally Church, PhD will be attending the 6th International Society of Gastroenterological Carcinogenesis (ISGC) meeting in Houston from Thursday 6th to Saturday, 8th January, 2011. Hosted by the MD Anderson Cancer Center, the meeting has an impressive line up of key opinion leaders. Further information can be found on the Pharma Strategy Blog.
December 22nd, 2010
Published by Pieter Droppert on Biotech Strategy Blog